Bouke de Jong

Medicine & Life Sciences

1. Tuberculosis 100%
2. Mycobacterium tuberculosis 88%
3. Rifampin 49%
4. Buruli Ulcer 45%
5. Mycobacterium 29%
6. Multidrug-Resistant Tuberculosis 25%
7. Sputum 22%
8. Gambia 20%
9. Mycobacterium ulcerans 20%
10. Pharmaceutical Preparations 19%
11. Drug Resistance 19%
12. Isoniazid 17%
13. Mutation 17%
14. bedaquiline 16%
15. Western Africa 15%
16. Fluoroquinolones 15%
17. Whole Genome Sequencing 13%
18. Democratic Republic of the Congo 12%
19. HIV 11%
20. Enzyme-Linked Immunospot Assay 10%
21. Genome 9%
22. Niger 9%
23. High-Throughput Nucleotide Sequencing 9%
24. Ethiopia 9%
25. T-Lymphocytes 9%
26. Gatifloxacin 8%
27. Comoros 8%
28. Pyrazinamide 8%
29. Lymph Node Tuberculosis 8%
30. Pulmonary Tuberculosis 8%
31. Cetylpyridinium 8%
32. Therapeutics 7%
33. Agar 7%
34. Extensively Drug-Resistant Tuberculosis 7%
35. Population 7%
36. Mali 7%
37. Benin 6%
38. Ghana 6%
39. Clofazimine 6%
40. Peru 6%
41. Guinea 6%
42. Genotype 6%
43. Antigens 6%
44. Multiple Drug Resistance 5%
45. Mycobacterium bovis 5%
46. Kanamycin 5%
47. Skin 5%
48. Polymerase Chain Reaction 5%
49. diacetylfluorescein 5%
50. Latent Tuberculosis 5%